Resultados de la búsqueda 471-480 of 15647 for thyroid%20disorders

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  2. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body disease, and ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to learn about the effects of three study medicines (encorafenib, cetuximab, and pembrolizumab) given together for the treatment of ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other places in the ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  6. Tuberous Sclerosis Clinic - Panorama general

    TS is a complex genetic disorder characterized by noncancerous (benign) tumors in many parts of the body, including the skin, brain, kidney and other organs ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare disease-free survival (DFS) of patients with high-risk cutaneous squamous cell carcinoma (CSCC) treated with adjuvant ...

  8. Control del estrés - Mayo Clinic

    Stress management: Learn why you feel stress and how to fight it.

  9. Trastornos de la personalidad - Diagnóstico y tratamiento - Mayo Clinic

    Personality disorders. In: Kaplan & Sadock's Comprehensive Textbook of Psychiatry. 10th ed. Wolters Kluwer; 2017. https://ovidsp.ovid.com. Accessed June 9, 2023 ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the growth ...